Login | Register

Phase I Trial Of NTCELL® In Parkinson’s Disease Authorized In New Zealand

The New Zealand Minister of Health has authorized Living Cell Technologies Limited to proceed with Phase I clinical trials of NTCELL for the treatment of Parkinson's disease. The company says it is on track to start its first in-human trials in the first quarter of 2013...

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *